Neoplasia/BPH

	Empirical noise mapping guides optimal region-of-interest selection for accurate noise estimation in prostate DWI. J Appl Clin Med Phys Medved M, Chatterjee A, Yousuf A, Gundogdu B, Oto A, Karczmar GS. PMID: 42682154 [PubMed - indexed for MEDLINE]
	International Society of Urological Pathology Multidisciplinary Expert Consultation Conference on Evaluation of Treatment Effects in Prostate and Bladder Cancer: Working Group 2: The Urinary Bladder. Am J Surg Pathol Downes MR, Wobker SE, Smith SC, Eckstein M, Akgul M, Baydar DE, Brimo F, Compérat E, Hartmann A, Kamat AM, Lobo A, Raspollini MR, Sangoi AR, Shariat SF, Tsuzuki T, van Rhijn BWG, Williamson SR, van Leenders GJLH, Cheng L, Lopez-Beltran A, Members of ISUP GU Cancer Treatment Effects Consensus Panel. PMID: 42682094 [PubMed - as supplied by publisher]
	Primary malignant melanoma of the female urethra: a case report and literature review. Can J Urol Xie J, Zhang Q, Wu J, Ma Y, Yan Y, Huang X. PMID: 42682069 [PubMed - indexed for MEDLINE]
	Renal Ewing sarcoma with an unusual presentation: a case report. Can J Urol Lübbersmeyer F, Lindfeld P, Fisch M, Dahlem R, Von Deimling M. PMID: 42682068 [PubMed - indexed for MEDLINE]
	At a glans: metastatic prostate cancer disguised as penile squamous cell carcinoma; a case report. Can J Urol Narasimhan R, Sugiyama K, Wang J, Munarriz R, Sarita-Reyes C. PMID: 42682067 [PubMed - indexed for MEDLINE]
	450-nm blue laser vaporizationversustransurethral resection of the prostate for benign prostatic hyperplasia: a retrospective comparative study. Can J Urol Liu N, Zhang J, Liu W, Chen X, Li B. PMID: 42682065 [PubMed - indexed for MEDLINE]
	HypnoVRÂ®in minimally invasive surgical techniques (MISTs) for lower urinary tract symptoms (LUTS): a safe, sedation-reducing tool improving patient experience. Can J Urol Olivero A, Giudici S, Caviglia A, Palagonia E, Nizzardo M, Quistini A, Grasso A, Maltzman O, Colombo M, Tappero S, Mazzone E, Dell'Oglio P, Bocciardi AM, Galfano A, Secco S. PMID: 42682062 [PubMed - indexed for MEDLINE]
	Unintended consequences of antibiotic practices: the relationship between bowel preparation, prolonged prophylaxis, and ileus after radical cystectomy. Can J Urol Manivasagam SS, Clark JY, Raman JD. PMID: 42682052 [PubMed - indexed for MEDLINE]
	Safety and outcomes of salvage HoLEP after TURP: a comparative study. Can J Urol Sabur V, Gölba. PMID: 42682050 [PubMed - indexed for MEDLINE]
	Impact of leuprolide and goserelin on androgen suppression and adverse events in patients with prostate cancer. Can J Urol Freitas CSM, Rocha-Silva F, Marques-Silva TA, de Oliveira ACR, da Silva SG, Santos Cardoso FD, Soares AN. PMID: 42682049 [PubMed - indexed for MEDLINE]
	Prostatic morcellation after HoLEP Enucleation: efficiency and safety of Storz DrillCut vs. Jena Surgical Multicut Solo. Can J Urol Bergadá L, Olivera JR, Tirapegui FI, Cristallo C, Santillán D, Yanzi GM, Segura M, Ramos J, Tobia I, Sebastián González M. PMID: 42682048 [PubMed - indexed for MEDLINE]
	Prostate volume on transrectal ultrasound: comparing ultrasounds performed by urologists to radiologists. Can J Urol Henckes ME, Cleynenbreugel BV. PMID: 42682047 [PubMed - indexed for MEDLINE]
	Pathologic failure and salvage approaches following focal therapy for localized prostate cancer. Can J Urol Tremblay S, Tabei SS, Tayebi S, Hinrichs BH, Lazarovich A, Koehler J, Hsu WW, Verma S, Sidana A. PMID: 42682046 [PubMed - indexed for MEDLINE]
	Efficacy and safety of blue laser vaporization of the prostate for benign prostatic hyperplasia: a systematic review and meta-analysis. Can J Urol Yu RP, Song OY, Weng H, Wang YB, Li BH, Zi H, Hao Y, Li Q, Zeng XT. PMID: 42682042 [PubMed - indexed for MEDLINE]
	Artificial intelligence advances in cystoscopy and imaging for bladder cancer: a narrative review. Can J Urol Khalid U, Shah N, Kavia R, Batura D. PMID: 42682041 [PubMed - indexed for MEDLINE]
	Prognostic value of circulating tumor DNA and copy-number alterations in patients receiving tandem [(225)Ac]Ac-/[(177)Lu]Lu-PSMA-617 therapy for metastatic castration-resistant prostate cancer: a prospective observational study. BMC Cancer Amghar M, Hielscher T, Rausch T, Özgür H, Bauder-Wüst U, Rathke H, Bruchertseifer F, Morgenstern A, Roscher M, Bene, Kratochwil C, Bene. PMID: 42681619 [PubMed - indexed for MEDLINE]
	Eosinophil Proportion May Serve as a Candidate Biomarker for Adverse Events in Patients With Urothelial Carcinoma Treated With Enfortumab Vedotin. Cancer Med Odagiri K, Morikawa T, Naiki T, Sugiyama Y, Tasaki Y, Mimura Y, Naiki-Ito A, Nagai T, Etani T, Iida K, Ishikawa D, Noda Y, Shimizu N, Aoki M, Gonda M, Banno R, Kubota H, Ando R, Umemoto Y, Kawai N, Furukawa-Hibi Y, Yasui T. PMID: 42681561 [PubMed - indexed for MEDLINE]
	Delphi consensus of specialist radiologists on imaging criteria for gadolinium contrast use and whole-body MRI in prostate cancer. Insights Imaging Onwuharine EN, Clark AJ, Dimmock M, Hill J. PMID: 42681263 [PubMed]
	Renal cell carcinoma: molecular understanding and therapeutic development. Cell Death Differ Hou T, Hua X, Ni W, Yan P, Inuzuka H, Wei W. PMID: 42680845 [PubMed - as supplied by publisher]
	Editorial for "Accuracy of Quantitative Chemical-Exchange-Saturation-Transfer Imaging for Grading Prostate Cancer and Predicting Adverse Pathology". J Magn Reson Imaging Zu Z. PMID: 42680717 [PubMed - as supplied by publisher]

Articles 1 - 20 / 190975

Page 1 of 9549



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy